Nothing Special   »   [go: up one dir, main page]

AU2001261732A1 - Composition for delivery of compounds to cells - Google Patents

Composition for delivery of compounds to cells

Info

Publication number
AU2001261732A1
AU2001261732A1 AU2001261732A AU6173201A AU2001261732A1 AU 2001261732 A1 AU2001261732 A1 AU 2001261732A1 AU 2001261732 A AU2001261732 A AU 2001261732A AU 6173201 A AU6173201 A AU 6173201A AU 2001261732 A1 AU2001261732 A1 AU 2001261732A1
Authority
AU
Australia
Prior art keywords
delivery
cells
compounds
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001261732A
Inventor
Betsy T. Kren
Cheryle Linehan-Stieers
R. Scott Mcivor
Clifford J. Steer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Minnesota System
Original Assignee
BETSY T KREN
CHERYLE LINEHAN STIEERS
SCOTT MCIVOR R
University of Minnesota Twin Cities
University of Minnesota System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BETSY T KREN, CHERYLE LINEHAN STIEERS, SCOTT MCIVOR R, University of Minnesota Twin Cities, University of Minnesota System filed Critical BETSY T KREN
Publication of AU2001261732A1 publication Critical patent/AU2001261732A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2001261732A 2000-05-19 2001-05-19 Composition for delivery of compounds to cells Abandoned AU2001261732A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US20600200P 2000-05-19 2000-05-19
US60/206,002 2000-05-19
US28512101P 2001-04-20 2001-04-20
US60/285,121 2001-04-20
PCT/US2001/016015 WO2001089579A2 (en) 2000-05-19 2001-05-19 Composition for delivery of compounds to cells

Publications (1)

Publication Number Publication Date
AU2001261732A1 true AU2001261732A1 (en) 2001-12-03

Family

ID=26900956

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001261732A Abandoned AU2001261732A1 (en) 2000-05-19 2001-05-19 Composition for delivery of compounds to cells

Country Status (4)

Country Link
US (1) US20020115216A1 (en)
EP (1) EP1286699A2 (en)
AU (1) AU2001261732A1 (en)
WO (1) WO2001089579A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69841648D1 (en) 1997-03-11 2010-06-17 Univ Minnesota DNS-BASED TRANSPOSONE SYSTEM FOR THE INTRODUCTION OF NUCLEIC ACID IN THE DNA OF A CELL
US7160682B2 (en) 1998-11-13 2007-01-09 Regents Of The University Of Minnesota Nucleic acid transfer vector for the introduction of nucleic acid into the DNA of a cell
US7262056B2 (en) * 2001-11-08 2007-08-28 Mirus Bio Corporation Enhancing intermolecular integration of nucleic acids using integrator complexes
US7824910B2 (en) * 2001-11-29 2010-11-02 Nippon Shokubai Co., Ltd. Method of transducing a protein into cells
US8227432B2 (en) 2002-04-22 2012-07-24 Regents Of The University Of Minnesota Transposon system and methods of use
US20060026699A1 (en) * 2004-06-04 2006-02-02 Largaespada David A Methods and compositions for identification of genomic sequences
AU2009223313A1 (en) * 2008-03-14 2009-09-17 Egen, Inc. Biodegradable cross-linked branched poly (alkylene imines)
EP2731429A4 (en) * 2011-07-15 2015-03-04 Univ Georgia Compounds, methods of making, and methods of use
CN111700877A (en) 2014-09-03 2020-09-25 吉倪塞思公司 Therapeutic nanoparticles and related compositions, methods and systems
US20170000743A1 (en) 2015-07-02 2017-01-05 Vindico NanoBio Technology Inc. Compositions and Methods for Delivery of Gene Editing Tools Using Polymeric Vesicles
US10456452B2 (en) 2015-07-02 2019-10-29 Poseida Therapeutics, Inc. Compositions and methods for improved encapsulation of functional proteins in polymeric vesicles
EP3449004B1 (en) 2016-04-29 2021-02-24 Poseida Therapeutics, Inc. Poly(histidine)-based micelles for complexation and delivery of proteins and nucleic acids

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0666923A1 (en) * 1991-09-05 1995-08-16 The University Of Connecticut Targeted delivery of poly- or oligonucleotides to cells
CA2135295A1 (en) * 1992-06-17 1993-12-23 Chu Jung Arabinogalactan derivatives and uses thereof
US5948681A (en) * 1996-08-14 1999-09-07 Children's Hospital Of Philadelphia Non-viral vehicles for use in gene transfer
EP1034258A2 (en) * 1997-11-13 2000-09-13 The Regents Of The University Of Minnesota Nucleic acid transfer vector for the introduction of nucleic acid into the dna of a cell
JP2002515418A (en) * 1998-05-20 2002-05-28 エクスプレッション・ジェネティックス・インコーポレーテッド Polymer gene carrier for polyethylene glycol conjugated poly-L-lysine targeting hepatocytes

Also Published As

Publication number Publication date
EP1286699A2 (en) 2003-03-05
WO2001089579A2 (en) 2001-11-29
WO2001089579A3 (en) 2002-08-29
US20020115216A1 (en) 2002-08-22

Similar Documents

Publication Publication Date Title
AU2001280767A1 (en) Peptide-mediated delivery of molecules into cells
AU2002210993A1 (en) Medicinal compositions for concominant use as anticancer agents
AU2001259846A1 (en) Methods and compositions for enhancing the delivery of a nucleic acid to a cell
AU2277101A (en) Stable extended release oral dosage composition
AU5033800A (en) Ascorbic acid derivative composition for increasing cell renewal rate
AU2093101A (en) Compositions for efficient release of active ingredients
AU1998100A (en) Novel curative for anaerobic adhesive compositions
AU2002218751A1 (en) Stable radiopharmaceutical compositions
AU2002220533A1 (en) Dermal anti-inflammatory composition
AU2001282301A1 (en) Fuel composition
IL152084A0 (en) Topical compositions containing prostaglandin e1
AU2001233691A1 (en) Antiperspirant compositions
AU2001258677A1 (en) Novel compounds having antiinflammatory activity: process for their preparation and pharmaceutical compositions containing them
AU2001262733A1 (en) Medicinal compositions containing propenone derivatives
AU2001285790A1 (en) Antiperspirant compositions
AU2001261732A1 (en) Composition for delivery of compounds to cells
AU2001268131A1 (en) Stabilized compositions containing oxygen-labile active agents
AU2002256304A1 (en) Compositions for delivery of compounds to cells and methods of use
AU5622300A (en) Stable l-ascorbic acid composition
AU2003205717A1 (en) New medicinal compositions containing heterocyclical compounds in addition to anticholinergics
AU7937500A (en) Pharmaceutical composition containing midazolam
AU3317200A (en) Antiperspirant compositions containing isopropyl glycerol ether
AU2001271391A1 (en) Novel compositions for use as electrode materials and for hydrogen production
AU4317500A (en) Antibiral compositions containing phorbol derivatives as the main active ingredient
AU2001245615A1 (en) Pouched composition